Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
26 Feb 2026 Job Information Organisation/Company INSERM U1112 Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Positions Postdoc Positions Application Deadline 1 Apr
-
of Dr. Rita Manco, based at INSERM UMR1011. We are a young, growing, and highly motivated group working to understand how vascular remodeling controls liver fibrosis and regeneration. The project will be
-
11 Feb 2026 Job Information Organisation/Company IRMETIST INSERM U1313 Research Field Biological sciences » Biology Biological sciences » Biological engineering Medical sciences Researcher Profile
-
Description Work environment: This project is part of an INSERM-PCSI programme conducted in collaboration with the IRMB (INSERM–CHU Saint-Éloi), the IBMM (UM–CNRS) and the L2C (UM–CNRS), which is the host
-
13 Jan 2026 Job Information Organisation/Company Inserm 1266 Department Institut de Psychiatrie et Neuroscience de Paris (Inserm 1266) Research Field Biological sciences » Other Neurosciences
-
(who will be the main supervisor for the appointed postdoctoral candidate) at the University of Oslo, there are three co-PIs; Florent Sebbane at, INSERM, Lille, France , Philip Slavin, University
-
The Institute for Translational Medicine and Liver Disease (ITM) Inserm U1110, University of Strasbourg France, directed by Prof. Thomas F. Baumert, is seeking an outstanding Principal Investigator
-
, there are three co-PIs; Florent Sebbane at, INSERM, Lille, France , Philip Slavin, University of Stirling, Stirling, UK , and Ulf Büntgen, University of Cambridge, Downing Place, Cambridge, UK . The appointed
-
la recherche médicale (INSERM), France) DC9: Psychotherapy process and psychological intervention techniques in psychedelic therapy: safety and efficacy (Champalimaud Foundation (CF), Portugal) DC10
-
proteins drive tumor growth and survival. Glynthera is part of the CRCM, an international cancer center affiliated to CRNS, INSERM, University Aix-Marseille and the Paoli-Calmettes Cancer Institute in